课题基金 / 基金详情

Artificial Red Cells : Physiological Importance of the Ligand Reaction Dynamism and the New Application for Ligand Therapy

Artificial Red Cells : Physiological Importance of the Ligand Reaction Dynamism and the New Application for Ligand Therapy
人工红细胞:配体反应动力学的生理重要性和配体治疗的新应用
批准号:
19300164
负责人:
SAKAI Hiromi
金额:
$12.31万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2007
资助国家:
日本
项目状态:
已结题
起止时间:
2007 至 2009

项目摘要

项目成果

SAKAI Hiromi的其他基金

相似基金

相关文献

中文摘要
翻译
化学修饰血红蛋白(Hb)溶液作为人工O_2载体表现出血管收缩和高血压,可能是由于内源性NO和CO作为血管松弛因子的高亲和力,以及由于更快的O_2释放诱导自调节性血管收缩。另一方面,细胞型乙型肝炎囊泡(HbV)不会引起这种副作用。本文通过物理化学技术分析了配体气体分子的反应,发现HbV的反应速度要慢得多,这是由于高浓度Hb溶液在细胞内形成气体扩散屏障,以及HbV在窄管中流动时,其横向扩散受到阻碍。此外,我们测试了HbV作为外源性CO载体,因为内源性CO具有细胞保护作用。在引起失血性休克后,用co结合HbV对大鼠进行复苏。在再灌注时表现出细胞保护作用,CO迅速解离,经肺呼出。未发现与一氧化碳毒性相关的症状。这一结果暗示了人造红细胞作为一种新的配体疗法的可能性。
英文摘要
Chemically modified hemoglobin (Hb) solutions as artificial O_2 carriers show vasoconstriction and hypertension presumably due to the high affinity for endogenous NO and CO as vasorelaxation factors, and due to the faster O_2-release that induces autoregulatory vasoconstriction. On the other hand, cellular-type Hb-vesicle (HbV) does not induce such side effects. Herein we analyzed the reactions of ligand gaseous molecules by physicochemical techniques, and found out that HbV shows much slower reactions and it is due to the intracellular gas diffusion barrier induced by a concentrated Hb solution, and the retarded lateral diffusion of HbV when it flows in a narrow tube. In addition, we tested HbV as an exogenous CO carrier because endogenous CO is cytoprotective. After inducing hemorrhagic shock, rats were resuscitated with CO-bound HbV. It showed cytoprotective effect at reperfusion, and CO was dissociated rapidly and exhaled through the lung. No symptom related to toxicity of CO was detected. The results imply the possibility of artificial red cells for a new ligand therapy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Effect of hemoglobin vesicles, cellular-type artificial oxygen carriers, on the ex vivo expansion of human hematopoietic stem/progenitor cells using a coculture system with human stromal cells
血红蛋白囊泡、细胞型人工氧载体对使用与人类基质细胞共培养系统的人类造血干/祖细胞的离体扩增的影响
DOI: --
发表时间: 2009
期刊: ASA1O J. 55
影响因子: --
作者: [M.Yamaguchi, et al.]
通讯作者: et al.
人工酸素運搬体.「からだと酸素の事典」酸素ダイナミクス研究会編.第5章:酸素の利用.pp.478-484
人工氧载体。氧气动力学研究组编辑的《身体和氧气百科全书》第5章:氧气的利用。
DOI: --
发表时间: 2009
期刊:
影响因子: --
作者: [堀之内宏久, 小林紘一, 酒井宏水, 土田英俊]
通讯作者: 土田英俊
DOI: 10.1124/dmd.109.027094
发表时间: 2009-07-01
期刊: DRUG METABOLISM AND DISPOSITION
影响因子: 3.9
作者: [Taguchi, Kazuaki, Urata, Yukino, Otagiri, Masaki]
通讯作者: Otagiri, Masaki
Hemoglobin encapsulation in vesicles retards NO- and CO-bindings and O2-release when perfused throughnarrow gas-permeable tubes
当通过狭窄的透气管灌注时,血红蛋白封装在囊泡中会延迟 NO 和 CO 的结合以及 O2 的释放
DOI: --
发表时间: 2010
期刊: Am.J.Physiol.Heart Circ.Physiol. 298
影响因子: --
作者: [H.Sakai, N.Okuda, A.Sato, S.Takeoka, E.Tsuchida.]
通讯作者: E.Tsuchida.
共 28 条
    Development of a portable training equipment for hemiplegic upper extremity
    • 批准号:
      15K12711
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $1.58万
    • 财政年份:
      2015
    • 负责人:
      SAKAI Hiromi
    • 依托单位:
    Microhemodynamic properties and gas reactions of abnormal RBCs in narrow tubes
    Bioengineering of artificial red cells for clinical application
    • 批准号:
      22300161
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.9万
    • 财政年份:
      2010
    • 负责人:
      SAKAI Hiromi
    • 依托单位:
    A study of Korean Diplomacy to Japan from 1876 to 1894
    海外基金